USE OF AMYLIN AGONISTS IN THE TREATMENT OF DIABETES MELLITUS

摘要

Peptides amylin (provisionally named diabetes associated peptide or DAP), carboxy terminally amidated amylin (amylin-NH2) and calcitonin gene related peptide (CGRP) or active fragments thereof are useful for the treatment of diabetes mellitus or hypoglycaemia. The peptides may be used together with insulin and conveniently administered parenterally in tree form of solution.